TABLE 1.
Clinical and histological feature of SMT‐FH, LM‐BN, and LMS
| Type | SMT‐FH | LM‐BN | LMS | P‐value | |
|---|---|---|---|---|---|
| No. cases (n) | 28 | 25 | 35 | ||
| Age (y) | Mean ± SEM | 40.97 ± 1.56 | 42.88 ± 2.01 | 55.62 ± 2.26 | <.001 |
| Tumor size (cm) | Mean ± SEM | 9.74 ± 0.84 | 6.28 ± 0.97 | 10.64 ± 1.25 | .0182 |
| Surgery type [n (%)] | Hysterectomy | 13 (46.4) | 21 (84.0) | 33 (94.3) | |
| Tumorectomy | 15 (53.6) | 4 (16.0) | 2 (5.7) | <.001 | |
| Severe nuclear atypia | Focal/multifocal | 78.6% | 60.7% | 0.0% | |
| Diffuse | 21.4% | 39.3% | 100% | <.001 | |
| Mitosis/10 HPF | <1 | 25.0% | 24.0% | 0.0% | |
| 1‐5 | 71.4% | 60.0% | 5.7% | ||
| 6‐10 | 3.6% | 16.0% | 5.7% | ||
| >10 | 0.0% | 0.0% | 88.6% | <.001 | |
| Tumor necrosis | Absence | 96.4% | 100% | 5.7% | |
| Focal | 3.6% | 8.6% | |||
| Extensive | 58.7% | <.001 | |||
| Follow‐up (mo) | Median (IQR) | 85.5 (28.8, 204.3) | 41.5 (12.8, 134.3) | 55.2 (13.7, 120.2) | |
| Overall survival | 1 y | 100% | 100% | 76% (64%, 91%) | |
| (95% CI) | 2 y | 100% | 100% | 68% (55%, 85%) | |
| 5 y | 100% | 100% | 50% (36%, 69%) |